The study showed that when taking the drug, patients progression-free rate of survival increased nearly 200 percent for those who continued medicating with rituximab.

When analyzing the diseased cells under a microscope, there is a protein that binds two separate diseases together.

Federal health officials explain that certain types of breast implants may increase risks of having anaplastic large cell lymphoma (ALCL), a very rare cancer.